Alpha-amylase variants stabilized against dimerization and/or multimerization, method for the production thereof, and detergents and cleansers containing these alpha-amylase variants

Patent metadata

Field	Value
Publication number	US-9353361-B2
Application number	US-201414300826-A
Country	US
Kind code	B2
Filing date	Jun 10, 2014
Priority date	Oct 1, 2004
Publication date	May 31, 2016
Grant date	May 31, 2016

Abstract

The present invention relates to α-amylase variants that are stabilized to dimerization and/or multimerization, in particular at elevated temperatures or high pH, by point mutagenesis of positively polarized or charged or neutral surface amino acids to give more negatively polarized or charged amino acids. The invention further relates to methods of increasing the stability of an α-amylase to dimerization and/or multimerization brought about by electrostatic interactions whereby at least one amino acid residue on the surface of the starting molecule, which makes a neutral or positively polar or charged contribution to the electrostatic potential of said molecule, is replaced with a more negatively polar or negatively charged amino acid residue. The α-amylase variants obtained thereby exhibit better stability to influences of the solvent, increased processivity, and are suited for numerous industrial areas of use, in particular as active ingredients in detergents and cleansers.

First claim

The invention claimed is:

1. A cell comprising a nucleic acid coding for an alpha-amylase variant of the alpha-amylase of Bacillus sp. A 7-7 (DSM 12368) according to positions +1 to 484 of SEQ ID NO: 2 and having alpha-amylase activity, the variant having a plurality of amino acid substitutions with respect to the alpha-amylase starting molecule, wherein the alpha-amylase variant differs from the alpha-amylase starting molecule by substitution of a plurality of predetermined starting amino acid residues at the surface of the molecule making a neutral or positively polar or charged contribution to the electrostatic potential of said molecule with more negatively polar or negatively charged substituted amino acid residues, thereby providing increased stability to aggregate formation,
wherein the amino acid substitutions are chosen from the following substitutions:

Starting amino acid
Substituted amino acid

Arg (R)
K, Y, C, H, G, A, V, L, I, M, F, W, P, S, T, N, Q, E or D

Lys (K)
Y, C, H, G, A, V, L, I, M, F, W, P, S, T, N, Q, E or D

Trp (W)
P, S, T, N, Q, E or D

Pro (P)
S, T, N, Q, E or D

Ser (S)
T, N, Q, E or D

Thr (T)
N, Q, E or D

Asn (N)
Q, E or D

Gln (Q)
E or D

wherein said starting amino acid residues are selected from the following positions:
83, 94, 118, 154, 172, 176, 260, 283, 302, 320, 323, 376, 400, 419, 422, 439, 444, 445, 459, and 463, in each case indicated in the numbering of the mature protein according to SEQ ID NO. 2, wherein the amino acid substitutions are limited to two or more of the listed positions, and wherein the number of substitutions is up to 20.

2. The cell of claim 1 , wherein said nucleic acid is part of a vector.

3. The cell of claim 1 , wherein the cell is a bacterium that secretes the alpha-amylase variant into the surrounding medium.

4. The cell of claim 1 , wherein the cell is a Gram-negative bacterium selected from the group consisting of the species Escherichia coli , the genus Klebsiella , the genus Pseudomonas , and the genus Xanthomonas.

5. The cell of claim 4 , wherein the cell is selected from the group consisting of the strains Escherichia coli BL21 (DE3), E. coli RV308, E. coli DH5alpha, E. coli JM109, E. coli XL-1, and Klebsiella planticola (Rf).

6. The cell of claim 1 , wherein the cell is a Gram-positive bacterium selected from the group consisting of the genera Bacillus, Staphylococcus , and Corynebacterium.

7. The cell according to claim 6 , wherein the cell is selected from the group consisting of the species Bacillus lentus, B. licheniformis, B. amyloliquefaciens, B. subtilis, B. globigii, B. alcalophilus, Staphylococcus carnosus , and Corynebacterium glutamicum.

Assignees

• Basf Se

Inventors

• Bessler Cornelius
• Wieland Susanne
• Maurer Karl-Heinz

Classifications

• C12N9/2417 Primary

  from microbiological source · CPC title

• C11D3/38681

  Chemically modified or immobilised enzymes · CPC title